Anti-HIF-2-alpha antibody (ab13704)
- Product nameAnti-HIF-2-alpha antibodySee all HIF-2-alpha primary antibodies ...
- DescriptionRabbit polyclonal to HIF-2-alpha
- Tested applicationsWB more details
- Species reactivityReacts with: Human
Synthetic peptide corresponding to Human HIF-2-alpha aa 426-443.
- Positive control
- Tested with HeLa cell lysate.
- Storage instructionsStore at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C. Avoid freeze / thaw cycle.
- Storage bufferPreservative: 0.02% Sodium azide
- Concentration information loading...
- PurityProtein A purified
- Clonality Polyclonal
- Pathways and Processes
- Metabolic signaling pathways
- Nucleotide metabolism
- Molecular processes
- Mitochondrial transcription
Our Abpromise guarantee covers the use of ab13704 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||WB: 1/500 - 1/1000. Detects a band of approximately 94 kDa (predicted molecular weight: 96 kDa).|
- FunctionTranscription factor involved in the induction of oxygen regulated genes. Binds to core DNA sequence 5'-[AG]CGTG-3' within the hypoxia response element (HRE) of target gene promoters. Regulates the vascular endothelial growth factor (VEGF) expression and seems to be implicated in the development of blood vessels and the tubular system of lung. May also play a role in the formation of the endothelium that gives rise to the blood brain barrier. Potent activator of the Tie-2 tyrosine kinase expression. Activation seems to require recruitment of transcriptional coactivators such as CREBPB and probably EP300. Interaction with redox regulatory protein APEX seems to activate CTAD.
- Tissue specificityExpressed in most tissues, with highest levels in placenta, lung and heart. Selectively expressed in endothelial cells.
- Involvement in diseaseDefects in EPAS1 are the cause of erythrocytosis familial type 4 (ECYT4) [MIM:611783]. ECYT4 is an autosomal dominant disorder characterized by increased serum red blood cell mass, elevated hemoglobin concentration and hematocrit, and normal platelet and leukocyte counts.
- Sequence similaritiesContains 1 basic helix-loop-helix (bHLH) domain.
Contains 1 PAC (PAS-associated C-terminal) domain.
Contains 2 PAS (PER-ARNT-SIM) domains.
modificationsIn normoxia, is probably hydroxylated on Pro-405 and Pro-531 by EGLN1/PHD1, EGLN2/PHD2 and/or EGLN3/PHD3. The hydroxylated prolines promote interaction with VHL, initiating rapid ubiquitination and subsequent proteasomal degradation. Under hypoxia, proline hydroxylation is impaired and ubiquitination is attenuated, resulting in stabilization.
In normoxia, is hydroxylated on Asn-847 by HIF1AN thus probably abrogating interaction with CREBBP and EP300 and preventing transcriptional activation.
Phosphorylated on multiple sites in the CTAD.
The iron and 2-oxoglutarate dependent 3-hydroxylation of asparagine is (S) stereospecific within HIF CTAD domains.
- Cellular localizationNucleus.
- Basic helix loop helix PAS protein MOP2 antibody
- Basic-helix-loop-helix-PAS protein MOP2 antibody
- bHLHe73 antibody
- Class E basic helix-loop-helix protein 73 antibody
- ECYT4 antibody
- Endothelial PAS domain containing protein 1 antibody
- Endothelial pas domain protein 1 antibody
- Endothelial PAS domain-containing protein 1 antibody
- EPAS 1 antibody
- EPAS-1 antibody
- EPAS1 antibody
- EPAS1_HUMAN antibody
- HIF 1 alpha like factor antibody
- HIF 2 alpha antibody
- HIF-1-alpha-like factor antibody
- HIF-2-alpha antibody
- HIF1 alpha like factor antibody
- HIF2-alpha antibody
- Hif2a antibody
- HLF antibody
- Hypoxia inducible factor 2 alpha antibody
- Hypoxia inducible factor 2 alpha subunit antibody
- Hypoxia-inducible factor 2-alpha antibody
- Member of PAS protein 2 antibody
- Member of pas superfamily 2 antibody
- MOP 2 antibody
- MOP2 antibody
- PAS domain-containing protein 2 antibody
- PASD2 antibody
Anti-HIF-2-alpha antibody images
Western blot analysis of HIF-2-alpha using ab13704 at 1:500 dilution against (A) cobalt chloride treated HeLa cells and (B) untreated HeLa cell lysate.
References for Anti-HIF-2-alpha antibody (ab13704)
ab13704 has not yet been referenced specifically in any publications.